TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods-Reference-Cited by-同舟云学术

TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods

Published:2014-12-20 Issue:5 Volume:36 Page:3371-3380
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Kantorova Barbara,Malcikova Jitka,Smardova Jana,Pavlova Sarka,Trbusek Martin,Tom Nikola,Plevova Karla,Tichy Boris,Truong Sim,Diviskova Eva,Kotaskova Jana,Oltova Alexandra,Patten Nancy,Brychtova Yvona,Doubek Michael,Mayer Jiri,Pospisilova Sarka

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-014-2971-0.pdf

Reference36 articles.

1. Butler T, Gribben JG. Biologic and clinical significance of molecular profiling in chronic lymphocytic leukemia. Blood Rev. 2010;24(3):135–41.

2. Pettitt AR, Jackson R, Carruthers S, Dodd J, Dodd S, Oates M, et al. Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial. J Clin Oncol. 2012;30(14):1647–55.

3. Moreno C, Montserrat E. New prognostic markers in chronic lymphocytic leukemia. Blood Rev. 2008;22(4):211–9.

4. Hillmen P. Using the biology of chronic lymphocytic leukemia to choose treatment. Hematology Am Soc Hematol Educ Program. 2011;2011:104–9.

5. Gonzalez D, Martinez P, Wade R, Hockley S, Oscier D, Matutes E, et al. Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial. J Clin Oncol. 2011;29(16):2223–9.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TP53 in AML and MDS: The new (old) kid on the block;Blood Reviews;2023-07

2. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Annals of Oncology;2021-01

3. Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods;Hematology, Transfusion and Cell Therapy;2020-07

4. TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics;Haematologica;2018-11-15

5. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation;Leukemia;2018-02-02